JANIMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Janimine, and when can generic versions of Janimine launch?
Janimine is a drug marketed by Abbott and is included in one NDA.
The generic ingredient in JANIMINE is imipramine hydrochloride. There are thirty-four drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Janimine
A generic version of JANIMINE was approved as imipramine hydrochloride by STRIDES PHARMA on October 21st, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for JANIMINE?
- What are the global sales for JANIMINE?
- What is Average Wholesale Price for JANIMINE?
Summary for JANIMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 69 |
| Patent Applications: | 3,904 |
| DailyMed Link: | JANIMINE at DailyMed |
US Patents and Regulatory Information for JANIMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | JANIMINE | imipramine hydrochloride | TABLET;ORAL | 017895-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbott | JANIMINE | imipramine hydrochloride | TABLET;ORAL | 017895-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbott | JANIMINE | imipramine hydrochloride | TABLET;ORAL | 017895-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
